All lobbying filings
THE WASHINGTON TAX & PUBLIC POLICY GROUP
Lobbying for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · Biopharmaceutical industry
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 13, 2026
Income
$70,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
3
-
GREGORY NICKERSONPreviously held: Tax Counsel, Ways and Means Committee; Staff Director, Ways and Means Select Revenue Measures Subcommittee
-
ZACHARY AUSTIN PRICEPreviously held: Staff Assistant to Sen. Coats
-
JAMES MAX PEDROTTI New on this filingPreviously held: Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Deputy Chief of Staff to Rep. Carol Miller
Government bodies contacted
2
Lobbying activity
1
Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income and the potential impacts on financial reporting and on the tax base of the U.S. and its Territories. Issues related to the taxation of intellectual property income. Issues related to IRC sections 11, 41 and 174, 55, 56A, and 59, 59A, 163(j), 168(k), 250, 951A (H.R. 1990, S. 1639, H.R. 1347, S. 559, S. 1688, H.R. 574, S. 187, H.R. 1062, S. 1605, S. 2021, H.R. 1 - Sections 70301, 70302, 70303, 70321, 70322, 70323, 70331, 70341, 70342, 70361.)